NO20080648L - Syntesemetoder med hoyt utbytte for fremstilling av organiske salter av strontium - Google Patents

Syntesemetoder med hoyt utbytte for fremstilling av organiske salter av strontium

Info

Publication number
NO20080648L
NO20080648L NO20080648A NO20080648A NO20080648L NO 20080648 L NO20080648 L NO 20080648L NO 20080648 A NO20080648 A NO 20080648A NO 20080648 A NO20080648 A NO 20080648A NO 20080648 L NO20080648 L NO 20080648L
Authority
NO
Norway
Prior art keywords
strontium
organic salts
preparation
high yield
synthesis methods
Prior art date
Application number
NO20080648A
Other languages
English (en)
Norwegian (no)
Inventor
Stephan Christgau
Jens E T Andersen
Original Assignee
Osteologix As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteologix As filed Critical Osteologix As
Publication of NO20080648L publication Critical patent/NO20080648L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/08—Malonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • C07C65/10—Salicylic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20080648A 2005-07-06 2008-02-06 Syntesemetoder med hoyt utbytte for fremstilling av organiske salter av strontium NO20080648L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200500990 2005-07-06
DKPA200501779 2005-12-16
PCT/DK2006/000396 WO2007003200A2 (en) 2005-07-06 2006-07-05 High yield synthesis methods for producing organic salts of strontium

Publications (1)

Publication Number Publication Date
NO20080648L true NO20080648L (no) 2008-02-06

Family

ID=37507793

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080648A NO20080648L (no) 2005-07-06 2008-02-06 Syntesemetoder med hoyt utbytte for fremstilling av organiske salter av strontium

Country Status (10)

Country Link
US (1) US20090137678A1 (de)
EP (1) EP1899314A2 (de)
JP (1) JP2009500358A (de)
KR (1) KR20080033236A (de)
AU (1) AU2006265491A1 (de)
BR (1) BRPI0612406A2 (de)
CA (1) CA2614226A1 (de)
NO (1) NO20080648L (de)
RU (1) RU2008104410A (de)
WO (1) WO2007003200A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1622630B1 (de) * 2003-05-07 2012-08-29 Osteologix A/S Strontium-kombinationsbehandlung zur prophylaxe/behandlung von knorpel- und knochenzuständen
ES2275218T3 (es) 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
US7589235B2 (en) 2004-05-06 2009-09-15 Osteologix, A/S High yield and rapid synthesis methods for producing metallo-organic salts
EP2416756A2 (de) 2009-04-10 2012-02-15 Mahmut Bilgic Stabile pharmazeutische zusammensetzungen mit hoher bioverfügbarkeit
EP2530068A1 (de) 2011-05-31 2012-12-05 Lacer, S.A. Neue Strontiumsalze, deren Synthese und Verwendung bei der Behandlung von Osteoporose
US10463636B2 (en) 2016-09-30 2019-11-05 Deanna J. Nelson Pharmaceutical quality strontium L-lactate
IL297415A (en) * 2020-04-22 2022-12-01 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd Active phenolate salt complex
CN114994195B (zh) * 2022-05-12 2024-12-31 上海应用技术大学 一种枸橼酸铁及其六种有机酸的高效液相色谱分离分析方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20014746D0 (no) * 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
EP1622630B1 (de) * 2003-05-07 2012-08-29 Osteologix A/S Strontium-kombinationsbehandlung zur prophylaxe/behandlung von knorpel- und knochenzuständen
AU2004237437B2 (en) * 2003-05-07 2011-01-20 Osteologix A/S Controlled release composition containing a strontium salt
ES2275218T3 (es) * 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
RU2007145207A (ru) * 2005-05-06 2009-06-20 Гленмарк Фармасьютикалз Лимитед (In) Стронциваемая соль эзомепразола, способ ее получения и содержащее ее фармацевтические композиции

Also Published As

Publication number Publication date
AU2006265491A1 (en) 2007-01-11
KR20080033236A (ko) 2008-04-16
RU2008104410A (ru) 2009-08-20
BRPI0612406A2 (pt) 2016-09-06
JP2009500358A (ja) 2009-01-08
EP1899314A2 (de) 2008-03-19
US20090137678A1 (en) 2009-05-28
WO2007003200A3 (en) 2007-09-27
CA2614226A1 (en) 2007-01-11
WO2007003200A2 (en) 2007-01-11

Similar Documents

Publication Publication Date Title
NO20080648L (no) Syntesemetoder med hoyt utbytte for fremstilling av organiske salter av strontium
ATE517088T1 (de) Carbazolderivat und herstellungsverfahren dafür
NO20074642L (no) Fremgangsmate for a lage trans-1-((1R,3S)-6-klor-3-fenylindan-1-yl)-3,3-dimetylpiperazin
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
MX340539B (es) Base de minociclina cristalina y procesos para su preparacion.
WO2007031548A3 (en) Processes for preparing of glucopyranosyl-substituted (ethynyl-benzyl)-benzene derivatives and intermediates thereof
NO20071012L (no) Fremgangsmate for fremstilling av D-erytro-2,2-difluor-2-deoksy-1-oksoribosederivat
NO20081621L (no) Tetrahydrokinoliner, syntese og intermediater
NO20081617L (no) Metoder for fremstilling av Glutaminsyrederivater
WO2011114210A3 (en) Processes for the preparation of linezolid
NO20080812L (no) Fremgangsmate for fremstilling av 4 β-amino-4'demetyl-4-4-desoksy podofyllotoksin
ZA201003751B (en) Process for the synthesis of propargylated aminoindan derivatives
WO2007033279A3 (en) System for producing chemical compounds via a baric electromagnetic thermal process
WO2018009602A3 (en) Novel processes for preparation of soluble guanylate cyclase stimulators
DK2152667T3 (da) Fremgangsmåder til fremstilling af N-isobutyl-n-(2-hydroxy-3-amin-4-phenylbutyl)-p-nitrobenzenesulfonylamid-derivater
DK1877370T3 (da) Fremgangsmåde til fremstilling af hydrazon-derivater
BRPI0606976A2 (pt) processo para preparação de intermediários
WO2010140132A8 (en) Process for the preparation of crystalline aprepitant having form i content
WO2014133291A9 (ko) (2rs)-아미노-(3s)-히드록시-부티르산 또는 이의 유도체의 제조방법
NO20084839L (no) Metoder for fremstilling av glutaminsyrederivater og melomprodukter
EA200901088A1 (ru) Способ получения 5-бензилокси-2-(4-бензилоксифенил)-3-метил-1н-индола
WO2016058881A3 (en) Process for the preparation of 1-(3,5-dichlorophenyl)-2,2,2-trifluoroethanone and derivatives thereof
Wang et al. A facile one-pot synthesis of chromeno [4, 3-b][1, 5] naphthyridines
MX2009013336A (es) Sintesis de 3-aminopirazoles sustituidos.
WO2008006574A3 (de) Nitrobenzol-derivate sowie ein verfahren zum herstellen dieser 1' alkylnitrobenzole und alkylaniline

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application